Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 534 of 1,261
  1. US 10125139

    Pesticidally active polycyclic derivatives with sulfur substituted five-membered ring heterocycles

    SYNGENTA (CHINA) INVESTMENT CO. LTD. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  2. US 10125369

    PCSK9 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  3. US 10124043

    Mutant OPAA enzymes with increased catalytic efficiency on organophosphorus compound EA1356

    The United States of America as represented by the Secretary of the Army · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  4. US 10123989

    Method of lowering cholesterol

    Med-Life Discoveries LP · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  5. US 10118902

    Small molecule agonists of neurotensin receptor 1

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  6. US 10119140

    Methods for enhancing or decreasing the levels of MIR124 and MIR29 in subjects with muscular dystrophy

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  7. US 10118961

    Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV

    CytomX Therapeutics, Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  8. US 10119172

    Methods and reagents for detecting ebola virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  9. US 10119143

    Compositions and methods for inhibiting expression of the ALAS1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  10. US 10118942

    Toll-like receptor 2 ligands and methods of making and using thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  11. US 10118932

    Solid state forms of spiro-oxindole compounds

    Xenon Pharmaceuticals Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  12. US 10118923

    Compositions and methods for inhibiting kinases

    Inhibikase Therapeutics, Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  13. US 10118881

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  14. US 10117947

    Virus-like particle conjugates for diagnosis and treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  15. US 10117944

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  16. US 10117941

    Lipids and compositions for the delivery of therapeutics

    ARBUTUS BIOPHARMA CORPORATION · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  17. US 10117942

    Photoactivatable lipid-based nanoparticles as vehicles for dual agent delivery

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  18. US 10117915

    Modulation of yeast-based immunotherapy products and responses

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  19. US 10117936

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    TONIX PHARMA LIMITED · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  20. US 10117928

    Annexin II compositions

    Regents of the University of Minnesota · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  21. US 10117937

    Highly branched alpha-D-glucans

    Phytoption LLC · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  22. US 10117912

    Drug delivery method

    Regents of the University of Minnesota · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  23. US 10117899

    Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells

    Sangamo Therapeutics, Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  24. US 10117882

    Anti-inflammatory properties of marine lipid compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.